Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis (Q73292547)
Jump to navigation
Jump to search
scientific article published on 01 December 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis |
scientific article published on 01 December 1999 |
Statements
Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis (English)
Karim A
Tolbert DS
Hunt TL
Hubbard RC
Harper KM
1 December 1999